Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 6895730, 13 pages
https://doi.org/10.1155/2017/6895730
Research Article

Extracellular Signal-Regulated Kinase 5 is Required for Low-Concentration H2O2-Induced Angiogenesis of Human Umbilical Vein Endothelial Cells

1Department of Plastic and Reconstructive Surgery, Chinese PLA General Hospital, Beijing 100853, China
2Medicine School of Chinese PLA, Beijing 100853, China
3Department of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
4Institute of Basic Medicine, Chinese PLA General Hospital, Beijing 100853, China
5Medicine School of Nankai University, Tianjin 300071, China

Correspondence should be addressed to Yan Han; moc.361@53368002731 and Weidong Han; moc.oohay@96wsrdwnah

Received 23 November 2016; Revised 22 February 2017; Accepted 9 March 2017; Published 30 April 2017

Academic Editor: Arianna Scuteri

Copyright © 2017 Shan Jiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Kurzyk, “Angiogenesis—possibilities, problems and perspectives,” Postepy Biochemii, vol. 61, no. 1, pp. 25–34, 2015. View at Google Scholar · View at Scopus
  2. E. Panieri and M. M. Santoro, “ROS signaling and redox biology in endothelial cells,” Cellular and Molecular Life Sciences, vol. 72, no. 17, pp. 3281–3303, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Oshikawa, S.-J. Kim, E. Furuta et al., “Novel role of p66shc in ROS-dependent VEGF signaling and angiogenesis in endothelial cells,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 302, no. 3, pp. H724–H732, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. N. García-Quintans, C. Sánchez-Ramos, A. Tierrez et al., “Control of endothelial function and angiogenesis by PGC-1α relies on ROS control of vascular stability,” Free Radical Biology and Medicine, vol. 75, no. 1, p. S5, 2014. View at Publisher · View at Google Scholar
  5. G. D. Kim, J. Oh, H.-J. Park, K. Bae, and S. K. Lee, “Magnolol inhibits angiogenesis by regulating ROS-mediated apoptosis and the PI3K/AKT/mTOR signaling pathway in mES/EB-derived endothelial-like cells,” International Journal of Oncology, vol. 43, no. 2, pp. 600–610, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Son, Y. K. Cheong, N. H. Kim, H. T. Chung, D. G. Kang, and H. O. Pae, “Mitogen-activated protein kinases and reactive oxygen species: how can ROS activate MAPK pathways?” Journal of Signal Transduction, vol. 2011, Article ID 792639, 6 pages, 2011. View at Publisher · View at Google Scholar
  7. Y. Sun, W. Z. Liu, T. Liu, X. Feng, N. Yang, and H. F. Zhou, “Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis,” Journal of Receptors and Signal Transduction, vol. 35, no. 6, pp. 600–604, 2015. View at Publisher · View at Google Scholar
  8. X. Wang and C. Tournier, “Regulation of cellular functions by the ERK5 signalling pathway,” Cellular Signalling, vol. 18, no. 6, pp. 753–760, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Ulrich-Merzenich, H. Zeitler, D. Panek, D. Bokemeyer, and H. Vetter, “Vitamin C promotes human endothelial cell growth via the ERK-signaling pathway,” European Journal of Nutrition, vol. 46, no. 2, pp. 87–94, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. G. N. Nithianandarajah-Jones, B. Wilm, C. E. P. Goldring, J. Müller, and M. J. Cross, “The role of ERK5 in endothelial cell function,” Biochemical Society Transactions, vol. 42, no. 6, pp. 1584–1589, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Giulivi, P. Hochstein, and K. J. A. Davies, “Hydrogen peroxide production by red blood cells,” Free Radical Biology and Medicine, vol. 16, no. 1, pp. 123–129, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Roy, S. Khanna, K. Nallu, T. K. Hunt, and C. K. Sen, “Dermal wound healing is subject to redox control,” Molecular Therapy, vol. 13, no. 1, pp. 211–220, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. C. P. Regan, W. Li, D. M. Boucher, S. Spatz, M. S. Su, and K. Kuida, “Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 14, pp. 9248–9253, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. S. J. Sohn, B. K. Sarvis, D. Cado, and A. Winoto, “ERK5 MAPK regulates embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expression,” Journal of Biological Chemistry, vol. 277, no. 45, pp. 43344–43351, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Yan, J. Carr, P. R. Ashby, V. Murry-Tait, C. Thompson, and J. S. C. Arthur, “Knockout of ERK5 causes multiple defects in placental and embryonic development,” BMC Developmental Biology, vol. 3, p. 11, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Hayashi, S.-W. Kim, K. Imanaka-Yoshida et al., “Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure,” Journal of Clinical Investigation, vol. 113, no. 8, pp. 1138–1148, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Pi, C. Yan, and B. C. Berk, “Big mitogen-activated protein kinase (BMK1)/ERK5 protects endothelial cells from apoptosis,” Circulation Research, vol. 94, no. 3, pp. 362–369, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Chis, P. Sharma, N. Bousette et al., “α-crystallin B prevents apoptosis after H2O2 exposure in mouse neonatal cardiomyocytes,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 303, no. 8, pp. H967–H978, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. E. De Marinis, M. Fiocchetti, F. Acconcia, P. Ascenzi, and M. Marino, “Neuroglobin upregulation induced by 17β-estradiol sequesters cytocrome c in the mitochondria preventing H2O2-induced apoptosis of neuroblastoma cells,” Cell Death and Disease, vol. 4, no. 2, p. e508, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Shimizug, R. Miyakura, and Y. Otsuka, “Nuclear receptor subfamily 4, group A, member 1 inhibits extrinsic apoptosis and reduces caspase-8 activity in H2O2-induced human HUC-F2 fibroblasts,” Redox Report, vol. 20, no. 2, pp. 81–88, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. J.-I. Abe, M. Kusuhara, R. J. Ulevitch, B. C. Berk, and J.-D. Lee, “Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase,” Journal of Biological Chemistry, vol. 271, no. 28, pp. 16586–16590, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. J.-I. Abe, M. Takahashi, M. Ishida, J.-D. Lee, and B. C. Berk, “c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1 (BMK1),” Journal of Biological Chemistry, vol. 272, no. 33, pp. 20389–20394, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Hayashi and J.-D. Lee, “Role of the BMK1/ERK5 signaling pathway: lessons from knockout mice,” Journal of Molecular Medicine, vol. 82, no. 12, pp. 800–808, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. V. K. Lai, M. Ashraf, S. Jiang, and K. H. Haider, “MicroRNA-143 is a critical regulator of cell cycle activity in stem cells with co-overexpression of Akt and angiopoietin-1 via transcriptional regulation of Erk5/cyclin D1 signaling,” Cell Cycle, vol. 11, no. 4, pp. 767–777, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Wang, Q. Li, C. Wang et al., “Knock-down of CIAPIN1 sensitizes K562 chronic myeloid leukemia cells to imatinib by regulation of cell cycle and apoptosis-associated members via NF-κB and ERK5 signaling pathway,” Biochemical Pharmacology, vol. 99, pp. 132–145, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Dong, J. S. Gutkind, and A. C. Larner, “Granulocyte colony-stimulating factor induces Erk5 activation, which is differentially regulated by protein-tyrosine kinases and protein kinase C: regulation of cell proliferation and survival,” Journal of Biological Chemistry, vol. 276, no. 14, pp. 10811–10816, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Sharma and M. L. Goalstone, “Regulation of ERK5 by insulin and angiotensin-II in vascular smooth muscle cells,” Biochemical and Biophysical Research Communications, vol. 354, no. 4, pp. 1078–1083, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Li, W. Wang, Y.-W. Pan, L. Xu, and Z. Xia, “A hydroxylated metabolite of flame-retardant PBDE-47 decreases the survival, proliferation, and neuronal differentiation of primary cultured adult neural stem cells and interferes with signaling of ERK5 map kinase and neurotrophin 3,” Toxicological Sciences, vol. 134, no. 1, pp. 111–124, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. X. Wang, A. J. Merritt, J. Seyfried et al., “Targeted deletion of mek5 causes early embryonic death and defects in the extracellular signal-regulated kinase 5/myocyte enhancer factor 2 cell survival pathway,” Molecular and Cellular Biology, vol. 25, no. 1, pp. 336–345, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. O. L. Roberts, K. Holmes, J. Müller, D. A. E. Cross, and M. J. Cross, “ERK5 is required for VEGF-mediated survival and tubular morphogenesis of primary human microvascular endothelial cells,” Journal of Cell Science, vol. 123, no. 18, pp. 3189–3200, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Gomez, T. Erazo, and J. M. Lizcano, “ERK5 and cell proliferation: nuclear localization is what matters,” Frontiers in Cell and Developmental Biology, vol. 4, p. 105, 2016. View at Publisher · View at Google Scholar
  32. T. Li, Y. W. Pan, W. Wang et al., “Targeted deletion of the ERK5 MAP kinase impairs neuronal differentiation, migration, and survival during adult neurogenesis in the olfactory bulb,” PLoS ONE, vol. 8, no. 4, Article ID e61948, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Zuo, Y. Wu, B. Wehrli, S. Chakrabarti, and C. Chakraborty, “Modulation of ERK5 is a novel mechanism by which Cdc42 regulates migration of breast cancer cells,” Journal of Cellular Biochemistry, vol. 116, no. 1, pp. 124–132, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Huang, J. Yao, B. Zhu, J. Zhang, and T. Sun, “Mitogen-activated protein kinase 7 promotes cell proliferation, migration and invasion in SOSP-M human osteosarcoma cell line,” Tumori Journal, 2015. View at Publisher · View at Google Scholar
  35. D. Spiering, M. Schmolke, N. Ohnesorge et al., “MEK5/ERK5 signaling modulates endothelial cell migration and focal contact turnover,” Journal of Biological Chemistry, vol. 284, no. 37, pp. 24972–24980, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. R. K. Komaravolu, C. Adam, J.-R. A. J. Moonen, M. C. Harmsen, M. Goebeler, and M. Schmidt, “Erk5 inhibits endothelialmigration via KLF2-dependent down-regulation of PAK1,” Cardiovascular Research, vol. 105, no. 1, pp. 86–95, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Dinev, B. W. M. Jordan, B. Neufeld et al., “Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells,” EMBO Reports, vol. 2, no. 9, pp. 829–834, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. E. J. Carter, R. A. Cosgrove, I. Gonzalez et al., “MEK5 and ERK5 are mediators of the pro-myogenic actions of IGF-2,” Journal of Cell Science, vol. 122, no. 17, pp. 3104–3112, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. S. H. Choi, D. Ruggiero, R. Sorice et al., “Six novel loci associated with circulating vegf levels identified by a meta-analysis of genome-wide association studies,” PLoS Genetics, vol. 12, no. 2, Article ID e1005874, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Kerbel and J. Folkman, “Clinical translation of angiogenesis inhibitors,” Nature Reviews Cancer, vol. 2, no. 10, pp. 727–739, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Hayashi, C. Fearns, B. Eliceiri, Y. Yang, and J.-D. Lee, “Big mitogen-activated protein kinase 1/extracellular signal-regulated kinase 5 signaling pathway is essential for tumor-associated angiogenesis,” Cancer Research, vol. 65, no. 17, pp. 7699–7706, 2005. View at Publisher · View at Google Scholar · View at Scopus